Published in Osteoporos Int on July 21, 2015
Monocyte Heterogeneity: Consequences for Monocyte-Derived Immune Cells. J Immunol Res (2016) 0.80
Integrative Analysis of Transcriptomic and Epigenomic Data to Reveal Regulation Patterns for BMD Variation. PLoS One (2015) 0.80
Cytosolic proteome profiling of monocytes for male osteoporosis. Osteoporos Int (2016) 0.76
Amyloid β Peptide Enhances RANKL-Induced Osteoclast Activation through NF-κB, ERK, and Calcium Oscillation Signaling. Int J Mol Sci (2016) 0.75
Mass spectrometry based proteomics profiling of human monocytes. Protein Cell (2016) 0.75
Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 26.08
Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36
Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity (2003) 21.56
Osteoclast differentiation and activation. Nature (2003) 18.59
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell (1998) 17.76
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A (1998) 12.61
The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature (1990) 8.94
Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol (2009) 8.67
Langerhans cells renew in the skin throughout life under steady-state conditions. Nat Immunol (2002) 7.03
Nomenclature of monocytes and dendritic cells in blood. Blood (2010) 6.63
A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science (2005) 5.88
Macrophage receptors and immune recognition. Annu Rev Immunol (2005) 5.83
Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity (2010) 5.43
Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med (2000) 5.02
Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell (2007) 4.71
TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem (1997) 4.61
Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci U S A (1990) 4.40
The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol (2002) 3.75
IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest (2005) 3.56
Cells in the marginal zone of the spleen. Int Rev Cytol (1992) 3.27
Distinct differentiation potential of blood monocyte subsets in the lung. J Immunol (2007) 3.16
Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med (1999) 3.07
Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med (2003) 3.02
Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem (2000) 2.80
Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature (2009) 2.79
Myeloid lineage commitment from the hematopoietic stem cell. Immunity (2007) 2.76
Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood (2011) 2.74
Turnover of resident microglia in the normal adult mouse brain. Neuroscience (1992) 2.73
Interleukin-1beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells. Bone (1999) 2.69
TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med (1998) 2.68
SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood (2011) 2.66
Monocyte subpopulations and their differentiation patterns during infection. J Leukoc Biol (2007) 2.51
Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem (1994) 2.45
Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science (1976) 2.23
Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med (2005) 2.21
Sex steroids and bone. Recent Prog Horm Res (2002) 2.17
Differential chemokine receptor expression and function in human monocyte subpopulations. J Leukoc Biol (2000) 2.12
A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A (2003) 2.09
The three human monocyte subsets: implications for health and disease. Immunol Res (2012) 2.08
Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Exp Cell Res (1999) 2.06
Peripheral blood CD14high CD16+ monocytes are main producers of IL-10. Scand J Immunol (2008) 1.99
Studying the mononuclear phagocyte system in the molecular age. Nat Rev Immunol (2011) 1.93
Mechanisms of sex steroid effects on bone. Biochem Biophys Res Commun (2005) 1.89
Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin. Nat Immunol (2009) 1.88
Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis. Rheumatology (Oxford) (2002) 1.87
Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood (1996) 1.87
alphavbeta3 and macrophage colony-stimulating factor: partners in osteoclast biology. Immunol Rev (2005) 1.81
Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol (2003) 1.76
TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology (2002) 1.72
Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci U S A (1987) 1.70
Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D. Proc Natl Acad Sci U S A (2013) 1.70
Rapid progression to AIDS in HIV+ individuals with a structural variant of the chemokine receptor CX3CR1. Science (2000) 1.70
Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL. Bone (2000) 1.66
Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med (1993) 1.63
Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology (2000) 1.61
Osteoclast precursors, RANKL/RANK, and immunology. Immunol Rev (2005) 1.57
Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci U S A (1989) 1.54
Origins and tissue-context-dependent fates of blood monocytes. Immunol Cell Biol (2008) 1.50
Expression of the M-CSF (CSF-1) gene by human monocytes. Blood (1987) 1.49
A role for TGFbeta(1) in osteoclast differentiation and survival. J Cell Sci (2000) 1.47
Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res (2001) 1.47
Toward a refined definition of monocyte subsets. Front Immunol (2013) 1.45
Ligation of TLR5 promotes myeloid cell infiltration and differentiation into mature osteoclasts in rheumatoid arthritis and experimental arthritis. J Immunol (2014) 1.44
Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand. Diabetologia (2008) 1.43
Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration. J Bone Miner Res (2003) 1.40
Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage. J Leukoc Biol (2009) 1.34
RANK Expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. J Bone Miner Res (2006) 1.33
Optimal timing to repopulation of resident alveolar macrophages with donor cells following total body irradiation and bone marrow transplantation in mice. J Immunol Methods (2004) 1.32
Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation. Mod Rheumatol (2012) 1.32
A novel pathophysiological mechanism for osteoporosis suggested by an in vivo gene expression study of circulating monocytes. J Biol Chem (2005) 1.30
Enhanced frequencies of CD14++CD16+, but not CD14+CD16+, peripheral blood monocytes in severe asthmatic patients. Clin Immunol (2008) 1.29
Dual origin of mouse spleen macrophages. J Exp Med (1984) 1.28
Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo. J Exp Med (2010) 1.28
Preactivated peripheral blood monocytes in patients with essential hypertension. Hypertension (1999) 1.26
Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors. J Immunol (2009) 1.25
Macrophage colony-stimulating factor and interleukin-1 alpha maintain the survival of osteoclast-like cells. Endocrinology (1995) 1.24
Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-kappaB signaling pathways. J Biol Chem (2008) 1.24
Endothelial differentiation potential of human monocyte-derived multipotential cells. Stem Cells (2006) 1.20
Identification of a human peripheral blood monocyte subset that differentiates into osteoclasts. Arthritis Res Ther (2006) 1.20
Cellular biology of bone-resorbing cells. J Bone Joint Surg Am (1996) 1.17
CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis. Arthritis Res Ther (2010) 1.17
Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts. J Bone Miner Res (2005) 1.16
Regulation of adult bone turnover by sex steroids. J Cell Physiol (2010) 1.15
Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro. Endocrinology (1998) 1.14
Monocytes from circulating blood fuse in vitro with purified osteoclasts in primary culture. J Cell Sci (1984) 1.14
Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res (2005) 1.12
Development, differentiation, and maturation of Kupffer cells. Microsc Res Tech (1997) 1.12
Osteoclast motility: putting the brakes on bone resorption. Ageing Res Rev (2009) 1.12
Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis. Proc Natl Acad Sci U S A (2010) 1.11
Interleukin-21 promotes osteoclastogenesis in humans with rheumatoid arthritis and in mice with collagen-induced arthritis. Arthritis Rheum (2012) 1.08
Macrophage colony-stimulating factor release and receptor expression in bone cells. J Bone Miner Res (1993) 1.07
Cytokine-induced osteoclastic bone resorption in charcot arthropathy: an immunohistochemical study. Foot Ankle Int (2006) 1.06
Identification of a gene module associated with BMD through the integration of network analysis and genome-wide association data. J Bone Miner Res (2010) 1.05
Derivation of multipotent progenitors from human circulating CD14+ monocytes. Exp Hematol (2010) 1.05
Cardiomyogenic potential of mesenchymal progenitors derived from human circulating CD14+ monocytes. Stem Cells Dev (2005) 1.05
Identification, characterization, and isolation of a common progenitor for osteoclasts, macrophages, and dendritic cells from murine bone marrow and periphery. J Bone Miner Res (2013) 1.02
The proliferative human monocyte subpopulation contains osteoclast precursors. Arthritis Res Ther (2009) 1.01